Brexafemme (ibrexafungerp) partners GSK and Scynexis have worked out their quarrel related to a clinical trial that was previously put on hold, leaving Scynexis with a $22 million payout. Per the ...

GSK committed $270 million up front in recent months to gain access to early-stage assets in the class of cancer therapies known as antibody drug conjugates, or ADCs. The deals are part of a broad ...

No articles found. GlaxoSmithKline France did not contribute to any primary research papers from Nature Index journals in the current 12 month window. Identify research insights to guide research ...

> Federal authorities want to seize 3,200 cases of products held in a warehouse by GNC, the country's largest supplement seller, saying they contain the stimulant dimethylamylamine, which the FDA in ...

According to sources, MRM has resigned Marie France and GlaxoSmithKline. At the same time, the agency is restructuring its Shanghai and Beijing offices, centralising its resources in Beijing as it ...

Type: Vaccine incorporating Sanofi’s S-protein COVID-19 antigen, which is based on recombinant DNA technology; and GSK’s pandemic AS03 adjuvant 2022 Status: Sanofi and GSK said February 23 that they ...

GSK plc, aka GlaxoSmithKline, is rated a Buy at or below $45 due to relative undervaluation and a balanced, diversified portfolio. GSK's recent CEO transition and solid Q2 earnings have improved ...

LONDON - GlaxoSmithKline [LSE: GSK] today reinforced its commitment to responsible management of ethical, social and environmental concerns and, in particular, to play a leading role in supporting ...